Deal Summary

enGene

$125,000,000

Amended and restated loan and security agreement

Hercules Capital

Deal Notes:

To strengthen balance sheet and provide financial flexibility

Industry:

Genetic medicines

Role:

Lender

Event:

Recapitalization

Recent Deal Announcements